Ichosia Biotechnology
Verified IntelIchosia Biotechnology is developing a scalable method of mass-producing an enhanced red blood product, Erythrosyn, by leveraging proprietary genetic engineering techniques. Erythrosyn is created by genetically engineering human stem cells to transform into fully functioning red blood cell. By transitioning this natural erythropoietin process from the body into the laboratory, Erythrosyn is being designed to be producible on demand, universally compatible and more cost effective than donor blood.
Ichosia Biotechnology is developing a scalable method of mass-producing an enhanced red blood product, Erythrosyn, by leveraging proprietary genetic engineering techniques. Erythrosyn is created by genetically engineering human stem cells to transform into fully functioning red blood cell. By transitioning this natural erythropoietin process from the body into the laboratory, Erythrosyn is being designed to be producible on demand, universally compatible and more cost effective than donor blood.
Corporate Firmographics
Entity classification and operating profile
- Industry
- Biotechnology
- Company Type
- Privately Held
- Founded
- 2019
- Employee Bracket
- 1-10
- Estimated Revenue Range
- Undisclosed
Geographic Coordinates
Headquarters address and regional territory
- Street Address
- 17 Briden St Massachusetts Worcester
- City
- Columbia
- Region / State
- South Carolina
- Postal Code
- 01605
- Country
- United States
Digital Presence & Footprint
Verified domains, socials, and directory profiles
Frequently Asked Questions
Verified business inquiries and firmographic telemetry for Ichosia Biotechnology.